Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $39.44 in the prior trading day, Structure Therapeutics Inc ADR (NASDAQ: GPCR) closed at $39.32, down -0.30%. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 0.63 million shares were traded. GPCR stock price reached its highest trading level at $40.71 during the session, while it also had its lowest trading level at $38.75.
Ratios:
Our goal is to gain a better understanding of GPCR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.14 and its Current Ratio is at 19.14. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 09, 2024, initiated with a Overweight rating and assigned the stock a target price of $65.
On October 19, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $90.
On July 27, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $58.Piper Sandler initiated its Overweight rating on July 27, 2023, with a $58 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GPCR now has a Market Capitalization of 1833051264 and an Enterprise Value of 5034834944.
Stock Price History:
The Beta on a monthly basis for GPCR is -3.74, which has changed by 0.654534 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, GPCR has reached a high of $75.02, while it has fallen to a 52-week low of $21.79. The 50-Day Moving Average of the stock is -0.34%, while the 200-Day Moving Average is calculated to be -10.16%.
Shares Statistics:
The stock has traded on average 574.34K shares per day over the past 3-months and 485930 shares per day over the last 10 days, according to various share statistics. A total of 46.41M shares are outstanding, with a floating share count of 41.44M. Insiders hold about 11.06% of the company’s shares, while institutions hold 80.99% stake in the company. Shares short for GPCR as of 1713139200 were 4114099 with a Short Ratio of 7.16, compared to 1710460800 on 3241403. Therefore, it implies a Short% of Shares Outstanding of 4114099 and a Short% of Float of 10.4899995.
Earnings Estimates
The performance of Structure Therapeutics Inc ADR (GPCR) in the stock market is under the watchful eye of 5.0 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$0.22, while EPS last year was -$1.14. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.18 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.83 and -$0.92 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.95, with 7.0 analysts recommending between -$0.77 and -$1.1.
